Related Articles Infection with SARS CoV 2 in pregnancy Information and proposed care CNGOF Gynecol Obstet Fertil Senol 2020 Mar 18 Authors Peyronnet V Sibiude J Deruelle P Huissoud C Lescure X Lucet JC Mandelbrot L Nisand I Vayssi re C Yazpandanah Y Luton D Picone O Abstract A new coronavirus SARS CoV 2 highlighted at the end of 2019 in China is spreading across all continents Most often at the origin of a mild infectious syndrome associating mild symptoms fever cough myalgia headache and possible digestive disorders to different degrees SARS Covid 2 can cause serious pulmonary pathologies and sometimes death Data on the consequences during pregnancy are limited The first Chinese data published seem to show that the symptoms in pregnant women are the same as those of the general population There are no cases of intrauterine maternal fetal transmission but cases of newborns infected early suggest that there could be vertical perpartum or neonatal transmission Induced prematurity and cases of respiratory distress in newborns of infected mothers have been described Pregnancy is known as a period at higher risk for the consequences of respiratory infections as for influenza so it seems important to screen for Covid 19 in the presence of symptoms and to monitor closely pregnant women In this context of the SARS Covid 2 epidemic the societies of gynecology obstetrics infectious diseases and neonatalogy have proposed a French protocol for the management of possible and proven cases of SARS Covid 2 in pregnant women These proposals may evolve on a daily basis with the advancement of the epidemic and knowledge in pregnant women Subsequently an in depth analysis of cases in pregnant women will be necessary in order to improve knowledge on the subject PMID 32199996 PubMed as supplied by publisher